INS and obesity disorder: Our previous studies show that SIT controls hyperglycemia and insulin resistance by promoting insulin signaling via activation of insulin receptor and glucose transporter 4 (GLUT 4) proteins in adipose tissues of obesity induced type-2 diabetic rats [15].